Drug: FLUDARA Injury: Acute lymphocytic leukaemia recurrent Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125089722 | FLUDARA | Acute lymphocytic leukaemia recurrent | AVENTIS | 50.00 YR | M | 0 | 20160727 | GB |
125319753 | FLUDARA | Acute lymphocytic leukaemia recurrent | AMGEN | 50.00 YR | M | 0 | 20160808 | GB |
125411441 | FLUDARA | Acute lymphocytic leukaemia recurrent | FRESENIUS KABI | 50.00 YR | M | 0 | 20160708 | GB |
125553242 | FLUDARA | Acute lymphocytic leukaemia recurrent | TEVA | 50.00 YR | M | 0 | 20160808 | GB |
127112121 | FLUDARA | Acute lymphocytic leukaemia recurrent | BAXTER | 5.41 YR | M | 0 | 20160902 | GR |
127160012 | FLUDARA | Acute lymphocytic leukaemia recurrent | NOVARTIS | 5.70 YR | M | 0 | 20160906 | GR |
Total Records: 6 Number of Pages: 1